BRAIN PRINT

 

SCROLL

2021/02/17

  • Information

LPIXEL Receives EN ISO 13485:2016 Medical Device Certification

Tokyo, Japan – February 17, 2021 – LPIXEL Inc., a leader in image analysis and processing in life science and medical research, announced today its achievement in gaining EN ISO 13485:2016 Medical Device Certification. It indicates that the LPIXEL’s Management System meets the most current regulatory requirements specific to the design, manufacture, and distribution of software used for analysis of medical diagnostic images.

About EIRL
EIRL is the collective name given to LPIXEL’s AI medical image diagnostic support technology. LPIXEL aims to provide solutions that enable a faster and more accurate diagnosis by implementing its unique algorithms to analyze medical big data, such as brain MRI, chest X-rays, and colonoscopy. For more information, please visit https://eirl.ai/en/

About LPIXEL
LPIXEL is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPIXEL is dedicated to offering research facilities, top-tier image analysis technologies and medical diagnosis technologies, both of which adopt advanced AI technology. LPIXEL revolves around business such as its medical image analysis software, “EIRL,” and its AI-based image analysis  service, “IMACEL.”
For more information, please visit https://lpixel.net/en/

Contact Information
LPIXEL Inc.
TEL:03-6259-1713 Email:pr@lpixel.net

PRODUCTS

EIRL
Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
IMACEL
AI Accelerating
Phase R&D
IMACEL, an image analysis AI, helps to solve various issues in the drug discovery process.
Life science and AI experts support successful AI implementation.

JOINT RESEARCH

PARTNERS

Alphabetical listing

CAREERS

A Third Career Option for Researchers

LPIXEL Inc.